• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2020 Jul 29;26(10).
doi: 10.3201/eid2610.202632. Online ahead of print.
Rapid Screening Evaluation of SARS-CoV-2 IgG Assays Using Z-Scores to Standardize Results

Marie K Das, Anu Chaudhary, Andrew Bryan, Mark H Wener, Susan L Fink, Chihiro Morishima

Abstract

Many serologic tests are now available for measuring severe acute respiratory syndrome coronavirus 2 antibodies to evaluate potential protective immunity and for seroprevalence studies. We describe an approach to standardizing positivity thresholds and quantitative values for different assays that uses z-scores to enable rapid and efficient comparison of serologic test performance.

Keywords: COVID19; IgG; SARS-CoV-2; antibody; coronavirus; coronavirus disease; performance; qualitative results; quantitative results; respiratory infections; screening; serologic analysis; severe acute respiratory syndrome coronavirus 2; standardization; viruses; z-scores; zoonoses.
 
Back
Top Bottom